[1]金银浩,刘桂清.载脂蛋白AⅡ基因-265T/C多态性与冠心病患者脂类代谢及冠脉狭窄程度相关性研究[J].陕西医学杂志,2023,52(10):1331-1334,1339.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.010]
　JIN Yinhao,LIU Guiqing.Correlation between apolipoprotein AⅡ gene 265T/C polymorphism and lipid metabolism and degree of coronary stenosis in patients with coronary heart disease[J].,2023,52(10):1331-1334,1339.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.010]
点击复制

载脂蛋白AⅡ基因-265T/C多态性与冠心病患者脂类代谢及冠脉狭窄程度相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年10期
页码:
1331-1334,1339
栏目:
临床研究
出版日期:
2023-10-05

文章信息/Info

Title:
Correlation between apolipoprotein AⅡ gene 265T/C polymorphism and lipid metabolism and degree of coronary stenosis in patients with coronary heart disease
作者:
金银浩1; 2; 刘桂清2
(1.锦州医科大学齐齐哈尔医学院附属第一医院研究生培养基地,黑龙江 齐齐哈尔161041; 2.齐齐哈尔医学院附属第一医院,黑龙江 齐齐哈尔161041)
Author(s):
JIN Yinhao; LIU Guiqing
(Graduate Student Training Base,the First Affiliated Hospital of Qiqihar Medical College,Jinzhou Medical University,Qiqihar 161041,China)
关键词:
冠心病;  载脂蛋白AⅡ基因-265T/C;  冠状动脉;  Gensini评分;  基因多态性;  狭窄
Keywords:
Coronary heart disease;  Apolipoprotein AⅡ gene-265T/C;  Coronary artery;  Gensini score;  Gene polymorphism;  Stenosis
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7377.2023.10.010
文献标志码:
A
摘要:
目的:探究载脂蛋白AⅡ基因-265T/C(ApoAⅡ-265T/C)多态性与冠心病(CHD)患者脂类代谢及冠脉狭窄程度相关性。方法:选择96例CHD患者为研究组。另取同期健康体检者100例作为对照组。分别采集研究组入院后翌日清晨空腹静脉血以及对照组入院当天空腹静脉血。通过聚合酶链反应结合限制片段长度多态性(PCR-RFLP)实现对所有受试者ApoAⅡ-265T/C基因多态性的检测。并通过全自动生化分析仪以及相关试剂盒完成血清脂代谢指标水平的检测。此外,对CHD患者开展冠脉造影,将所有CHD患者根据Gensini评分的差异分为轻度狭窄组(≤20分)、中度狭窄组(>20分且≤45分)及重度狭窄组(>45分)。比较研究组和对照组ApoAⅡ-265T/C基因多态性、血清脂代谢指标水平。分析不同冠脉狭窄程度CHD患者ApoAⅡ-265T/C基因多态性、血清脂代谢指标水平。并通过多因素Logistic回归分析明确CHD患者冠脉中/重度狭窄的影响因素。结果:CHD组血清ApoAⅠ及ApoB水平均低于对照组(均P<0.05),ApoAⅡ-265T/C多态性CC+CT基因型频率、C等位基因型频率高于对照组,差异有统计学意义(均P<0.05)。中/重度狭窄组患者的CC+CT基因型频率、C等位基因频率均高于轻度狭窄组,差异有统计学意义(均P<0.05)。中/重度狭窄组血清ApoAⅠ及ApoB水平均低于轻度狭窄组,差异有统计学意义(均P<0.05)。经多因素Logistic回归分析发现,CC+CT基因型频率以及C等位基因型均是CHD患者冠脉中/重度狭窄的危险因素(均P<0.05)。结论:CHD患者存在ApoAⅡ-265T/C基因CC+CT基因型频率、C等位基因型异常,且和CHD患者中/重度狭窄密切相关。
Abstract:
Objective:To investigate and analyze the correlation between apolipoprotein AⅡ gene 265T/C(ApoAⅡ-265T/C)polymorphism and lipid metabolism and coronary artery stenosis degree in patients with coronary heart disease(CHD).Methods:A total of 96 patients with CHD were enrolled as study group.Another 100 healthy subjects were selected as the control group.Fasting venous blood was collected in the early morning of the next day after admission in the study group and in the control group.ApoAⅡ-265T/C gene polymorphism was detected in all subjects by polymerase chain reaction combined with restricted fragment length polymorphism(PCR-RFLP).The level of serum lipid metabolism index was detected by automatic biochemical analyzer and related kits.In addition,coronary angiography was performed for CHD patients,and all CHD patients were divided into mild stenosis group(≤20 points),moderate stenosis group(> 20 points and ≤45 points)and severe stenosis group(> 45 points)according to Gensini scores.The levels of ApoAⅡ-265T/C gene polymorphism and serum lipid metabolism were compared between the study group and the control group.ApoAⅡ-265T/C gene polymorphism and serum lipid metabolism were analyzed in CHD patients with different degrees of coronary stenosis.Multivariate Logistic regression analysis was conducted to determine the influencing factors of moderate/severe coronary stenosis in CHD patients.Results:The levels of serum ApoAⅠ and ApoB in CHD group were lower than those in control group,and ApoAⅡ-265T/C polymorphic CC+CT genotype frequency and C allele genotype frequency were higher than those in control group(all P<0.05).CC+CT genotype frequency and C allele frequency in moderate and severe stenosis group were higher than those in mild stenosis group(all P<0.05).The levels of serum ApoAⅠ and ApoB in moderate and severe stenosis groups were lower than those in mild stenosis group(all P<0.05).Multivariate Logistic regression analysis showed that CC+CT genotype frequency and C allele were risk factors for moderate/severe coronary stenosis in CHD patients(all P<0.05).Conclusion:There are abnormal CC+CT genotype frequency and C allele of ApoAⅡ-265T/C gene in CHD patients,which are closely related to moderate/severe stenosis in CHD patients.

参考文献/References:

[1] 刘善宽,尹俊明.PCT、 CRP、血清胆红素、尿酸及载脂蛋白A1、B对冠心病的诊断价值[J].广东医学,2019,40(15):2246-2248.
[2] 温 祥,张 静,黄陆尧,等.安徽地区冠心病人群冠状动脉病变特征与载脂蛋白E基因多态性的研究[J].中国心血管病研究,2022,20(1):3-7.
[3] 中国心血管疾病监测、预防预警和治疗技术应用研究组.我国中年人群载脂蛋白B与载脂蛋白A-1比值对冠心病事件预测作用的研究[J].中国循环杂志,2021,36(11):1077-1082.
[4] 郝晋琳.脂蛋白a载脂蛋白B/载脂蛋白A同型半胱氨酸水平变化与冠心病患者Gensini评分的关联性分析[J].中国药物与临床,2021,21(10):1725-1727.
[5] 吴美美,王 虹,肖 双,等.载脂蛋白A5、载脂蛋白C3及载脂蛋白A5/C3比值与冠心病的关系[J].临床荟萃,2020,35(4):312-316.
[6] 梁有峰,郭 增,程宝山,等.非高密度脂蛋白胆固醇与载脂蛋白A-I比值与冠状动脉慢血流相关性分析[J].中国心血管病研究,2022,20(2):161-165.
[7] 苏广胜,付 茜,庞文跃.载脂蛋白B/载脂蛋白A1比值与青年冠心病患者冠状动脉病变严重程度的研究[J].临床心血管病杂志,2021,37(7):663-667.
[8] 韩 秀,田雨灵,卓小桢,等.载脂蛋白A、载脂蛋白B/载脂蛋白A比值与冠脉病变严重程度的相关性[J].西安交通大学学报:医学版,2019,40(2):255-258.
[9] 黄维华,吕田明,李焕敏,等.血清载脂蛋白AⅠ、B及其比值与脑白质变性严重程度的相关性[J].南方医科大学学报,2018,38(8):992-996.
[10] 黄子初.载脂蛋白CⅢ的检测及其与患者冠心病血脂的相关性分析[J].标记免疫分析与临床,2018,25(11):1623-1626.
[11] 朱友义,高律萍,曹成瑛,等.高原地区汉、藏族冠状动脉与颈动脉及下肢动脉粥样硬化病变程度相关性及危险因素比较研究[J].陕西医学杂志,2023,52(4):404-407.
[12] 张建标,马列婷.血脂和糖化血红蛋白对2型糖尿病合并冠心病的影响及早期诊断意义[J].陕西医学杂志,2014,43(11):1525.
[13] 邢丽君,魏月娟,纪立霞,等.补脾通络方治疗冠心病微血管心绞痛疗效研究[J].陕西中医,2023,44(3):316-319.
[14] 赵风琴.ApoB/ApoAⅠ与老年高血压患者缺血性脑白质病变的相关性[J].中国老年学杂志,2021,41(4):708-711.
[15] 赵 焕.对脂蛋白相关磷脂酶A2与冠心病及血脂指标、炎性标志物的相关性分析[J].当代医药论丛,2019,17(14):187-189.
[16] 张 蕊,赵 辉,赵福梅,等.载脂蛋白E启动子区域-427T/C多态性与冠心病的关系及其对转录活性的影响[J].天津医药,2019,47(8):842-847.
[17] 刘 宁,艾 英,刘 健.芦黄颗粒联合单硝酸异山梨酯治疗冠心病不稳定型心绞痛疗效及对患者心功能与脂代谢的影响[J].陕西中医,2023,44(1):64-67.
[18] 王宏伟,吕雪霞,胡吉东.同型半胱氨酸及血脂检测在心脑血管疾病预防治疗中的应用分析[J].临床检验杂志:电子版,2018,7(3):521-523.
[19] 陈丽娟,周宇生,栾 颖,等.TC/HDL-C联合HNP1-3、脂蛋白a检测在冠心病临床诊断中的应用[J].分子诊断与治疗杂志,2023,15(2):261-264.
[20] 肖 丽,周 军,王 栋.外显子8基因变异及高密度脂蛋白胆固醇与老年冠心病的关系[J].中华老年心脑血管病杂志,2022,24(10):1044-1047.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]汤克虎,高峻峰,任尽平.药物涂层球囊在糖尿病患者冠状动脉小血管病变治疗中的应用研究*[J].陕西医学杂志,2019,(4):432.
[3]马党捐 ,康彦智 ,柴茂林.64排128层螺旋CT冠状动脉成像在冠心病患者诊断中的价值研究*[J].陕西医学杂志,2019,(5):624.
　MA Dangjuan,KANG Yanzhi,CHAI Maolin..Value analysis of 64rows 128slice spiral CT coronary angiography in the diagnosis of patients with coronary heart disease[J].,2019,(10):624.
[4]沈 琳,马文苑.曲美他嗪联合氯吡格雷治疗冠心病心绞痛疗效及对患者心电图、血清超敏C反应蛋白和五聚素3的影响[J].陕西医学杂志,2019,(6):794.
　SHEN Lin,MA Wenyuan.ElectrocardiogramRoom,Therapeutic Effect ofTrimetazidine Combined with Clopidogrel on Angina Pectoris and its Hs-CRP[J].,2019,(10):794.
[5]杨延洁,周慧龙△.不同双抗血小板疗程对冠心病合并房颤PCI术后患者远期预后的影响*[J].陕西医学杂志,2019,(12):1653.
[6]魏 勇,梁 琪,左浩源,等.右美托咪定预处理对冠心病非心脏手术患者心肌的保护作用*[J].陕西医学杂志,2019,(12):1706.
　WEI Yong,LIANG Qi,ZUO Haoyuan,et al.Protective effect of dexmedetomidine preconditioning on myocardium in patients with coronary heart disease undergoing nonheart surgery[J].,2019,(10):1706.
[7]刘玉珊.心外膜脂肪定量及可溶性血栓调节蛋白与冠心病病变程度相关性分析[J].陕西医学杂志,2020,49(1):44.
　LIU Yushan..Correlation between the distribution of epicardial adipose tissue and soluble thrombomodulin and the severity of coronary heart disease[J].,2020,49(10):44.
[8]赵 博,王银谦,王红燕.巨噬细胞移动抑制因子与冠心病关系Meta分析[J].陕西医学杂志,2020,49(1):125.
[9]王亚平,彭春艳,朱名安Δ.冠心病合并代谢综合征患者固醇调节元件结合蛋白表达水平与脂代谢指标相关性研究*[J].陕西医学杂志,2020,49(4):419.
　WANG Yaping,PENG Chunyan,ZHU Mingan..Correlation between the levels of SREBPs and the indicators of lipid metabolism in patients with coronary heart disease complicated with metabolic syndrome[J].,2020,49(10):419.
[10]南格利.冠心病颈动脉超声参数与斑块稳定性及炎症反应水平相关性分析[J].陕西医学杂志,2020,49(4):453.
　NAN Geli..Correlation between carotid ultrasound parameters and plaque stability and inflammatory response in patients with coronary heart disease[J].,2020,49(10):453.

备注/Memo

备注/Memo:
基金项目:黑龙江省省属高等学校基本科研业务资助项目(2021-KYYWF-0339)
更新日期/Last Update: 2023-10-07